Search results
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Zacks via Yahoo Finance· 4 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
... Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients - Bristol-Myers Squibb...
Benzinga· 5 days agoOpdivo plus Yervoy combo shows significant survival benefits and higher response rates vs....
Lack of insurance may prevent Americans from accessing best cancer drugs
United Press International via Yahoo News· 5 days agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs,...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters· 7 days ago, opens new tab immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer...
Fake cancer drugs racket busted in Delhi, Syrian national among 4 arrested
Investing.com· 3 days agoOther accused were identified as Naveen...
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 2 days agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
I-Mab and BMS assess givastomig for gastric and oesophageal cancer
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) awarded orphan drug designation to givastomig to treat...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 6 days agoThe treatment, called Krazati, was little better than standard chemotherapy in a study enrolling about 300 patients with advanced non-small cell lung cancer, according to ...
ASCO24: Tagrisso in the spotlight, Caribou’s adjustment and Lilly’s KRAS competitor
BioPharma Dive via Yahoo Finance· 6 days agoAstraZeneca’s therapy could see wider use after ASCO data. Elsewhere, Caribou sought to explain an...
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID
Digital Journal· 6 days ago(NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. Aethlon Medical, Inc. (NASDAQ: AEMD) ...